These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5294300)

  • 1. Arterial infusion chemotherapy for carcinoma of the nasopharynx.
    Anderson JM; Fung JH; Laing D
    Br J Clin Pract; 1965 Oct; 19(10):565-7. PubMed ID: 5294300
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer chemotherapy by continuous intra-arterial infusion.
    Conn JH; Fain WR; Chavez CM; Rogers LS
    Bull Soc Int Chir; 1968; 27(6):588-99. PubMed ID: 5306670
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy with continuous infusion of cisplatin and 5-fluorouracil, with or without leucovorin, for locally advanced nasopharyngeal carcinoma.
    Fonseca E; Cruz JJ; Rodríguez CA; Gómez-Bernal A; Martín G; Sánchez P; Nieto A; Soria P; Vega MJ; Muñoz A; Pardal JL
    J Infus Chemother; 1996; 6(4):217-20. PubMed ID: 9229319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraarterial chemotherapy adjuvant to cryosurgery of oral cancer.
    Meyza JW
    Panminerva Med; 1975; 17(11-12):369-72. PubMed ID: 1084509
    [No Abstract]   [Full Text] [Related]  

  • 5. A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
    Chua DT; Sham JS; Au GK
    Head Neck; 2004 Feb; 26(2):118-26. PubMed ID: 14762880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
    Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
    Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Schwarz LR
    Cancer; 1996 Aug; 78(3):566-7. PubMed ID: 8697406
    [No Abstract]   [Full Text] [Related]  

  • 8. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
    Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
    Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.
    Rodriguez-Galindo C; Wofford M; Castleberry RP; Swanson GP; London WB; Fontanesi J; Pappo AS; Douglass EC
    Cancer; 2005 Feb; 103(4):850-7. PubMed ID: 15641027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined treatment of radiotherapy, neo-adjuvant chemotherapy and adjuvant chemotherapy for nasopharyngeal carcinoma].
    Takamura A; Saito H; Sakurai Y; Horio K; Hatayama N; Hangai K
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):569-71. PubMed ID: 8129404
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regional cytostatic chemotherapy of malignant tumors in the orofacial area].
    Bilder J
    Dtsch Zahnarztl Z; 1968 Jun; 23(6):648-54. PubMed ID: 5240553
    [No Abstract]   [Full Text] [Related]  

  • 13. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
    Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intra-arterial chemotherapy as a part of a combination-therapy in carcinoma of the oropharynx].
    Straehler-Pohl HJ; Koch U
    HNO; 1982 Aug; 30(8):311-6. PubMed ID: 6981633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial infusion chemotherapy of 5-FU and leucovorin for patients with liver metastases from colorectal cancer].
    Yamamura T; Hanai A; Oikawa H; Matsuzaki H; Kikuchi K; Akaishi O; Seo K; Ozasa T; Katayama K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1516-9. PubMed ID: 8373209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
    In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.
    Lin JC; Jan JS; Hsu CY; Jiang RS; Wang WY
    Br J Cancer; 2003 Jan; 88(2):187-94. PubMed ID: 12610501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Semicorporeal chemotherapy. The results in 110 cases of nasopharyngeal cancer (author's transl)].
    Xi N
    Zhonghua Zhong Liu Za Zhi; 1980 Mar; 2(1):63. PubMed ID: 7439003
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of regional intra-arterial induction chemotherapy for locally advanced nasopharyngeal carcinoma].
    Jiang G; Min H; Zhang J; Huang Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):376-9. PubMed ID: 12761949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.
    Wiemann MC; Cummings FJ; Kaplan HG; Spremulli EN; Doolittle CH; Calabresi P
    Cancer Res; 1982 Sep; 42(9):3896-900. PubMed ID: 6980707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.